Related Experiment Videos
Recent developments in hemoglobin-based oxygen carriers--an update on clinical trials.
1Hemosol, Inc, Toronto, Ont., Canada. lcarmichael@hemosol.com
Summary
Hemoglobin-based oxygen carriers (HBOCs) are nearing clinical approval after extensive research. Despite some limitations, HBOCs offer significant advantages and are expected to be available soon.
Area of Science:
- Biomedical engineering
- Hematology
- Drug development
Background:
- Hemoglobin-based oxygen carriers (HBOCs) have undergone extensive research and development.
- Several HBOC products are advancing towards final clinical stages and regulatory approval.
Purpose of the Study:
- To review the progress and clinical potential of HBOCs.
- To highlight the advantages and limitations of current HBOCs.
Main Methods:
- Literature review of HBOC development and clinical trials.
- Analysis of the benefits and drawbacks of HBOCs for clinical application.
Main Results:
- Significant advancements in HBOC technology.
- HBOCs show promise for future clinical use despite existing limitations.
Conclusions:
- HBOCs are poised to play a crucial role in clinical practice.
- Commercial availability of HBOCs is anticipated within two years.